会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • Devices and methods for occlusion of the uterine arteries
    • 用于闭塞子宫动脉的装置和方法
    • US20030216759A1
    • 2003-11-20
    • US10459342
    • 2003-06-10
    • Vascular Control Systems, Inc.
    • Fred BurbankMichael JonesPaul Lubock
    • A61B017/08
    • A61B8/12A61B8/06A61B8/0833A61B17/12013A61B17/42A61B18/1485
    • Devices and methods are disclosed for treating a uterine disorder which receive its blood supply from a uterine arteries. In particular, uterine fibroids are effectively treated by occluding the uterine arteries using trans-vaginal, trans-uterine, transrectal, or retroperitoneal approaches. The devices and methods are advantageous because the inventive procedures may be performed by a patient's gynecologist in the course of treatment, avoiding the need for referrals to specialist practitioners and for more radical treatments, such as hysterectomies. The methods include both temporary and permanent occlusion of the arteries. A cannula carries an imaging device and a member which will easily penetrate tissue, the member including a device which partially or completely, and temporarily or permanently, occludes a uterine artery.
    • 公开了用于治疗从子宫动脉接受其供血的子宫疾病的装置和方法。 特别地,子宫肌瘤通过使用经阴道,经子宫,经直肠或腹膜后方法闭塞子宫动脉来有效治疗。 所述装置和方法是有利的,因为本发明的方法可以由患者的妇科医生在治疗过程中进行,避免需要转诊给专科医师,以及进行诸如子宫切除术等更激进的治疗。 这些方法包括动脉的临时和永久闭塞。 套管携带成像装置和容易穿透组织的构件,该构件包括部分地或完全地暂时地或永久地阻塞子宫动脉的装置。
    • 8. 发明申请
    • Embolic occlusion of uterine arteries
    • 栓塞阻塞子宫动脉
    • US20040202694A1
    • 2004-10-14
    • US10411690
    • 2003-04-11
    • Vascular Control Systems, Inc.
    • Fred H. BurbankGreig AltieriMichael L. Jones
    • A61F006/06
    • A61L24/046A61L2430/36C08L67/04C08L71/02
    • A treatment procedure is disclosed which involves the short term, non-permanent occlusion of the patient's blood vessels by depositing a bioabsorbable embolic mass within the patient's blood vessel. The procedure is particularly suitable for treating uterine disorders by occluding a patient's uterine arteries. A therapeutically effective time period for occlusion of a uterine artery is from about 0.5 to about 48 hours, preferably about 1 to about 24 hours, with occlusion times of about 1 to about 8 hours being suitable in many instances. The embolic mass may bioabsorbable particulate with minimum transverse dimensions of about 100 to about 2000 micrometers, preferably about 300 to about 1000 micrometers. The particulate may be a polymeric material formed of polylactic acid, polyglycolic acid or copolymers thereof, or a swellable copolymer of lactic acid and polyethylene glycol. The embolic material may be delivered to an intracorporeal site as a biocompatible solution containing a solute which is relatively insoluble in a water based fluid and a solvent which is relatively soluble in the water based fluid, where the solute forms the embolic mass which occludes or partially occludes a body lumen or fills or partially fills a body cavity.
    • 公开了一种治疗方法,其涉及通过在患者的血管内沉积生物可吸收的栓塞物质而使患者的血管短期,非永久性闭塞。 该方法特别适用于通过阻塞患者的子宫动脉来治疗子宫疾病。 用于闭塞子宫动脉的治疗有效时间段为约0.5至约48小时,优选约1至约24小时,闭塞时间为约1至约8小时在许多情况下是合适的。 栓塞物质可具有约100至约2000微米,优选约300至约1000微米的最小横向尺寸的生物可吸收颗粒。 颗粒可以是由聚乳酸,聚乙醇酸或其共聚物或乳酸和聚乙二醇的可溶胀共聚物形成的聚合材料。 栓塞材料可以作为生物相容性溶液输送到体内部位,该溶液含有相对不溶于水基流体的溶质和相对可溶于水基流体的溶剂,其中溶质形成栓塞或部分的栓塞物质 封闭体腔或填充或部分填充体腔。
    • 9. 发明申请
    • Tenaculum-like device for intravaginal instrument delivery
    • 用于阴道内仪器输送的Tenaculum式装置
    • US20040158262A1
    • 2004-08-12
    • US10716329
    • 2003-11-18
    • Vascular Control Systems, Inc.
    • Fred H. BurbankMichael L. JonesGreig E. AltieriR.J. SerraEd OlsonYu-Tung Wong
    • A61B017/42
    • A61B17/4241A61B17/282A61B17/42
    • The invention is directed to tenaculum-like devices and systems for the intravaginal delivery of therapeutic or diagnostic devices and particularly for occluding a female patient's uterine arteries in order to treat uterine disorders. Included are methods for grasping, manipulating and retaining tissue. The tenaculum-type device has a distal portion with a sound configured to enter a cervical os without causing undue trauma or discomfort to the patient, and a retention or tissue grasping mechanism with a grasping element such as a spike configured to engage and retain a patient's cervix. The tenaculum-type devices embodying features of the invention may have an expandable distal tip to more securely be engaged within the patient's uterine cervical canal.
    • 本发明涉及用于治疗或诊断装置的阴道内输送的特定用途的器械和系统,特别是用于阻塞女性患者的子宫动脉以治疗子宫疾病。 包括用于抓握,操纵和保持组织的方法。 所述牵引式装置具有远端部分,其具有构造成进入颈部口的声音,而不会对患者造成不适当的创伤或不适;以及保持或组织夹持机构,其具有抓握元件,例如尖峰,其构造成接合并保持患者的 宫颈。 体现本发明的特征的憩室型装置可以具有可扩张的远端,以更可靠地接合在患者的子宫颈管内。
    • 10. 发明申请
    • Treatment for post partum hemorrhage
    • 治疗产后出血
    • US20040153097A1
    • 2004-08-05
    • US10355809
    • 2003-01-30
    • Vascular Control Systems, Inc.
    • Fred H. BurbankMichael L. JonesJill Uyeno
    • A61B017/42
    • A61B17/12A61B17/2812A61B17/42A61B2017/00057A61B2017/2837A61B2090/064A61B2090/378
    • The invention is directed to instruments and procedures using such instruments for temporarily reducing or terminating blood flow through a female patient's uterine artery to treat post partum hemorrhage (PPH). The uterine artery is occluded by a clamping device which includes a pair of pivotally connected clamping members, with each of the clamping members having a handle and a clamping element at the distal end of the handle. The clamping elements are inclined with respect to the longitudinal axes of the handles at an included obtuse angle between about 120null and about 170null, preferably between about 130null and 160null. An artery locating sensor is provided on the distal end of at least one of the clamping elements. Preferably, the artery locating sensor is a Doppler ultrasound blood flow sensor. After birth, the clamping device is inserted into the female patient's post partum vaginal canal and advanced therein until one of the clamping elements Is in the patient's uterine cervix and the other clamping element is on the exterior of the uterine cervix. The clamping element on the exterior of the patient's uterine cervix is pressed against the patient's vaginal formix and the clamping device closed so as to occlude the uterine artery disposed within tissue grasped by the clamping device. The clamping device is locked in the closed configuration and maintained in the condition until the patient's uterus is sufficiently clotted up to ensure termination of the hemorrhaging, typically about 5 minutes to about 7 hours.
    • 本发明涉及使用这种器械临时减少或终止通过女性患者子宫动脉的血液流动以治疗产后出血(PPH)的仪器和程序。 子宫动脉被包括一对枢转连接的夹紧构件的夹紧装置封闭,其中每个夹紧构件具有手柄和在手柄的远端处的夹紧元件。 夹紧元件相对于把手的纵向轴线以约120°至约170°之间,优选地在约130°至160°之间的包含的钝角倾斜。 动脉定位传感器设置在至少一个夹紧元件的远端上。 优选地,动脉定位传感器是多普勒超声血流传感器。 出生后,将夹紧装置插入雌性患者的产后阴道管中并推进到其中,直到其中一个夹紧元件位于患者的子宫颈中,而另一个夹紧元件位于子宫颈的外部。 患者子宫颈外侧的夹紧元件被压靠在患者的阴道结构上,并且夹紧装置关闭,以阻塞设置在由夹紧装置夹持的组织内的子宫动脉。 夹紧装置被锁定在闭合构型中并保持在状态,直到患者的子宫充分凝结,以确保终止出血,通常约5分钟至约7小时。